Neue Cyclopentanperhydrophenanthren-17beta-(hydroxy oder alkoxy)-17alpha-(aryl oder heterocyclyl)-3beta-derivate, die auf das kardiovaskuläre System wirken, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die diese enthalten

Cyclopentanperhydrophenanthren-17-(hydroxy or alkoxy)-17-(aryl or heterocyclyl)-3 beta -derivatives of general formula (I): wherein: the symbol @ means that the hydrogen in position 5 can have an alpha or beta configuration; the symbol --- represents either a single or a double bond; and X, R, R and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MELLONI, PIERO, BRESSO, MAILAND/MILANO, IT, VALENTINO, LOREDANA, BUCCINASCO, MAILAND/MILANO, IT, GOBBINI, MAURO, MERCALLO, VARESE, IT, FERRANDI, MARA, MAILAND/MILANO, IT, FRIGERIO, MARCO, MAILAND/MILANO, IT, TORRI, MARCO, RHO, MAILAND/MILANO, IT
Format:	Patent
Sprache:	ger
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS STEROIDS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Cyclopentanperhydrophenanthren-17-(hydroxy or alkoxy)-17-(aryl or heterocyclyl)-3 beta -derivatives of general formula (I): wherein: the symbol @ means that the hydrogen in position 5 can have an alpha or beta configuration; the symbol --- represents either a single or a double bond; and X, R, R and R have the meanings given in the description; a process for producing same and their use for the preparation of a medicament for the treatment of cardiavascular disorders such as heart failure and hypertension is disclosed.